WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and en

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

09:56pm, Monday, 12'th May 2025

OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer

OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates

06:35pm, Monday, 12'th May 2025

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.11 per share. This compares to loss of $0.11 per share a year ago.

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

04:05pm, Monday, 12'th May 2025

WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and en

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

04:05pm, Thursday, 01'st May 2025

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

07:30am, Wednesday, 23'rd Apr 2025

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach an

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

04:15pm, Friday, 18'th Apr 2025

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

11:56am, Wednesday, 12'th Mar 2025

OPTIMIZERx Corp. OPRX, a health care technology firm, reported on Wednesday fourth-quarter sales of $32.32 million, up 14% year-over-year, beating the consensus of $30.36 million.

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

11:04am, Wednesday, 12'th Mar 2025

OptimizeRx Corporation (NASDAQ:OPRX ) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Ope

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates

09:45am, Wednesday, 12'th Mar 2025

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

07:30am, Wednesday, 12'th Mar 2025

WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

07:30am, Tuesday, 11'th Mar 2025

WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by